Any healthcare professional with an interest in the care of neurosurgical patients is welcome to attend and participate in the annual meeting of the Neurosurgical Society of the Virginias. The meeting takes place at one of the premiere resorts of Virginia or West Virginia each January.
Our Honored Guest this year will be Dr. John Sampson, MD, PhD, MBA, MHSc, President of the PDC at Duke Health and former Chairman of the Department of Neurosurgery at Duke University.
The event will include Resident presentations in the morning where the top 6 resident abstracts (3 clinical and 3 basic sciences) will be given awards. Dr. Sampson will provide two Honored Guest lectures along with Attending neurosurgeon talks from the regional private practices and academic centers.
Registration includes admission to the meeting, one year membership in the Society, and CME certification.
Residents and medical students can register free of charge. Midlevel providers can attend free or pay $100 to get CME.
John H. Sampson, MD, PhD, MHSc, MBA is the Robert H. and Gloria Wilkins Distinguished Professor and Chair of Neurosurgery at Duke University School of Medicine, and co-leader of the Duke Cancer Institute Neuro-Oncology program.
Dr. Sampson is a recognized leader in the surgical resection and experimental treatment of complex brain tumors. He currently focuses his clinical practice on treating patients with benign and malignant brain tumors and divides his time between his clinical practice and an active research laboratory investigating new modalities of direct brain tumor infusion and immunotherapy.
After earning his medical degree from the University of Manitoba in Winnipeg, Dr. Sampson went on to pursue his PhD in neuropathology and MHSc in clinical research at Duke University. He did his research training under the internationally renowned scientist, Darell D. Bigner, and Nobel Laureate Gertrude Elion. Recognizing the need for additional health sector management and leadership training, he completed an MBA with Duke University’s Fuqua School of Business.
He has authored more than 240 peer-reviewed publications documenting the development of multiple immunotherapeutic agents that have affected the standard of care in glioblastoma multiforme, the most malignant form of brain cancer. He has remained continuously funded by the National Institutes of Health since 2000. In 2017, Dr. Sampson was named to the prestigious National Academy of Medicine. In 2018, elected as President, Private Diagnostic Clinic, PLLC at Duke.
Send this to a friend